Food and Drug Administration (FDA) approved Strattera for ADHD symptoms in adults and children over 6 years old in 2002 then approved the first generic versions of the drug in 2017
Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in
May 31, 2017 The FDA has approved the first generic version of Strattera, opening up a new nonstimulant treatment option for children and adults with ADHD
Strattera is
It belongs to the group
Strattera, a non-stimulant medication, may help improve ADHD symptoms without the risk of addiction by modifying brain chemistry
9
by Aallyah Wright June
Common side effects of atomoxetine may include: nausea, vomiting, upset stomach, constipation; dry mouth, loss of appetite; mood changes, feeling tired; dizziness; urination problems; or
5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1
Pooled analyses of short-term (6 to 18weeks) placebo-controlled trials of STRATTERA in children and adolescents (a total of 12trials involving over 2200 patients, including 11trials in ADHD and 1 trial in Strattera is a selective norepinephrine reuptake inhibitor medicine
Strattera has an FDA warning for increased risk of suicidal thoughts in Atomoxetine (Strattera) is an expensive drug used to treat attention deficit/hyperactivity disorder, also known as ADHD
, paroxetine, fluoxetine, and quinidine (see Drug-Drug Interactions under PRECAUTIONS)
Atomoxetine – In an uncontrolled trial, 12 individuals with hoarding disorder Strattera is a drug with peripheral sympathomimetic effects and should not generally be used in children, adolescents or adults with known structural cardiac abnormalities
More common side effects in children and adolescents taking Strattera include: nausea
Most side effects are mild and should go away after your body adjusts to the medication
Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials of STRATTERA in children and adolescents (a total of 12 trials involving over 2200 patients, including 11 trials in ADHD and 1 trial in enuresis) Dextroamphetamine
We also asked survey respondents to rate the efficacy of these top ADHD medications — specifically, we asked: “Overall, how effective would you say each medication was at managing ADHD symptoms?”
It was approved by the Food and Drug Administration (FDA) in 2002, and became the first non-stimulant medication to receive approval for ADHD
The capsule shells contain gelatin, sodium lauryl sulfate, and other inactive ingredients
Generically known as atomoxetine, many people who use it do not have a good understanding of the drug’s health effects
Medical professionals recommend Strattera as an integral part of a total treatment program for
STRATTERA is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years and older, adolescents and adults
STRATTERA may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD